PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33871064-0	2021	Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD.	NAD	160-163	CD38 antigen	Mus musculus	14-18	
33871064-4	2021	Our previous study demonstrated that deletion of CD38, which consumes NAD+ , suppressed cuprizone-induced demyelination, neuroinflammation and glial activation.	NAD	70-74	CD38 antigen	Mus musculus	49-53	
33871064-5	2021	However, it is still unknown whether CD38 directly affects neuroinflammation through regulating brain NAD+ level.	NAD	102-106	CD38 antigen	Mus musculus	37-41	
33871064-12	2021	These results suggest that CD38-mediated neuroinflammation is linked to NAD+ consumption and that boosting NAD+ by CD38 inhibition and NR supplementation directly suppress neuroinflammation in the brain.	NAD	72-76	CD38 antigen	Mus musculus	27-31	
33871064-12	2021	These results suggest that CD38-mediated neuroinflammation is linked to NAD+ consumption and that boosting NAD+ by CD38 inhibition and NR supplementation directly suppress neuroinflammation in the brain.	NAD	107-111	CD38 antigen	Mus musculus	115-119